View Older Stories View More Recent Stories

May 7, 2019 08:00AM Science2Startup Symposium Convened Close to 300 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections to Advance Scientific Innovation and Entre

May 2, 2019 09:03AM Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe M

Apr 24, 2019 04:43PM Form SC 13D/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 24, 2019 09:00AM Satsuma Pharmaceuticals Raises $62 Million in Series B Preferred Stock Financing

Apr 23, 2019 09:03AM Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal

Apr 15, 2019 04:36PM Form SC 13D/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 12, 2019 07:00AM Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners to Host Second Annual Science2Startup Symposium

Apr 10, 2019 05:22PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 10, 2019 07:30AM Inozyme Pharma Raises $67 Million in Series A2 Financing to Develop Therapies for Rare Mineralization Disorders

Mar 27, 2019 04:00PM Prevail Therapeutics Secures $50 Million in Series B Financing to Advance Pipeline of Gene Therapies for Neurodegenerative Diseases

Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Mar 14, 2019 09:03AM Ivantis Announces 24-Month Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial

Mar 7, 2019 08:00AM Stoke Therapeutics to Present on First Disease-Modifying Therapies for Genetic Epilepsies at Cowen and Company Annual Health Care Conference

Feb 26, 2019 07:30AM Behind the Seizure™ Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures

Feb 20, 2019 08:00AM Peloton Therapeutics Secures $150 Million in Series E Financing

Feb 14, 2019 05:16PM Form SC 13G RHYTHM PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G ARVINAS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Myovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:16PM Form SC 13G Crinetics Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Spero Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Biohaven Pharmaceutical Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A InflaRx N.V. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G/A Kadmon Holdings, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:15PM Form SC 13G ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:14PM Form SC 13G/A Krystal Biotech, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 14, 2019 05:01PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31

Feb 14, 2019 02:00AM Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Feb 11, 2019 04:52PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 11, 2019 04:51PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 28, 2019 04:34PM Form 4 Wave Life Sciences Ltd. For: Jan 24 Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 28, 2019 04:33PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC

Jan 23, 2019 08:38AM PlacementTracker Publishes 2018 PIPE and Private Placement Markets League Tables

Jan 9, 2019 10:37PM Black Diamond Therapeutics Closes $85 Million Series B Financing

Jan 7, 2019 08:00AM Apple Tree Partners Announces Partner and Team Promotions

Jan 3, 2019 07:30AM Sojournix Completes $44 Million Series C Financing

Dec 18, 2018 07:00AM Stoke Therapeutics Expands Senior Leadership Team, Adding Deep Expertise in Regulatory Affairs and Clinical Operations

Dec 17, 2018 06:15AM Form SC 13D Synthorx, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Dec 13, 2018 06:31PM Form 4 Synthorx, Inc. For: Dec 11 Filed by: RA CAPITAL MANAGEMENT, LLC

Dec 11, 2018 08:00AM WhiteSwell Announces $30 Million Financing for New Therapeutic Approach to Acute Decompensated Heart Failure

Dec 6, 2018 06:58PM Form 3 Synthorx, Inc. For: Dec 06 Filed by: RA CAPITAL MANAGEMENT, LLC

Dec 1, 2018 01:00PM Stoke Therapeutics Presents Data Showing Single Dose of ASO Therapy Restores Normal Protein Levels in Animal Model of Genetic Epilepsy

Nov 29, 2018 12:00AM ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

Nov 27, 2018 09:00AM Stoke Therapeutics to Present New Data on Lead Program at American Epilepsy Society's 2018 Annual Meeting

Nov 14, 2018 04:32PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30

Nov 7, 2018 06:14AM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Nov 2, 2018 06:05AM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

View More Recent Stories View Older Stories